{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "S1", "tokens": ["EBV", "Latent", "Membrane", "Protein", "1", "Activates", "Akt", ",", "NFkappaB", ",", "and", "Stat3", "in", "B", "Cell", "Lymphomas"], "sentence": "EBV Latent Membrane Protein 1 Activates Akt , NFkappaB , and Stat3 in B Cell Lymphomas", "event_mentions": [{"id": "E1", "event_type": "Positive_regulation", "trigger": {"text": "Activates", "start": 5, "end": 5}, "arguments": [{"entity_id": "T2", "text": "Akt", "role": "Theme"}, {"entity_id": "T1", "text": "Latent Membrane Protein 1", "role": "Cause"}]}, {"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "Activates", "start": 5, "end": 5}, "arguments": [{"entity_id": "T3", "text": "Stat3", "role": "Theme"}, {"entity_id": "T1", "text": "Latent Membrane Protein 1", "role": "Cause"}]}], "entity_mentions": [{"id": "T1", "text": "Latent Membrane Protein 1", "entity_type": "Protein", "start": 1, "end": 4}, {"id": "T2", "text": "Akt", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T3", "text": "Stat3", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T23", "text": "Activates", "entity_type": "Positive_regulation", "start": 5, "end": 5}]}
{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "S2", "tokens": ["Latent", "membrane", "protein", "1", "(", "LMP1", ")", "is", "the", "major", "oncoprotein", "of", "Epstein-Barr", "virus", "(", "EBV", ")", "."], "sentence": "Latent membrane protein 1 ( LMP1 ) is the major oncoprotein of Epstein-Barr virus ( EBV ) .", "event_mentions": [], "entity_mentions": [{"id": "T4", "text": "Latent membrane protein 1", "entity_type": "Protein", "start": 0, "end": 3}, {"id": "T5", "text": "LMP1", "entity_type": "Protein", "start": 5, "end": 5}]}
{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "S3", "tokens": ["In", "transgenic", "mice", ",", "LMP1", "promotes", "increased", "lymphoma", "development", "by", "12", "mo", "of", "age", "."], "sentence": "In transgenic mice , LMP1 promotes increased lymphoma development by 12 mo of age .", "event_mentions": [], "entity_mentions": [{"id": "T6", "text": "LMP1", "entity_type": "Protein", "start": 4, "end": 4}]}
{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "", "tokens": ["This", "study", "reveals", "that", "lymphoma", "develops", "in", "B-1a", "lymphocytes", ",", "a", "population", "that", "is", "associated", "with", "transformation", "in", "older", "mice", "."], "sentence": "This study reveals that lymphoma develops in B-1a lymphocytes , a population that is associated with transformation in older mice .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "S5", "tokens": ["The", "lymphoma", "cells", "have", "deregulated", "cell", "cycle", "markers", ",", "and", "inhibitors", "of", "Akt", ",", "NFkappaB", ",", "and", "Stat3", "block", "the", "enhanced", "viability", "of", "LMP1", "transgenic", "lymphocytes", "and", "lymphoma", "cells", "in", "vitro", "."], "sentence": "The lymphoma cells have deregulated cell cycle markers , and inhibitors of Akt , NFkappaB , and Stat3 block the enhanced viability of LMP1 transgenic lymphocytes and lymphoma cells in vitro .", "event_mentions": [{"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "inhibitors", "start": 10, "end": 10}, "arguments": [{"entity_id": "T7", "text": "Akt", "role": "Theme"}]}, {"id": "E4", "event_type": "Negative_regulation", "trigger": {"text": "inhibitors", "start": 10, "end": 10}, "arguments": [{"entity_id": "T8", "text": "Stat3", "role": "Theme"}]}], "entity_mentions": [{"id": "T7", "text": "Akt", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T8", "text": "Stat3", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T9", "text": "LMP1", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T24", "text": "inhibitors", "entity_type": "Negative_regulation", "start": 10, "end": 10}]}
{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "S6", "tokens": ["Lymphoma", "cells", "are", "independent", "of", "IL4", "/", "Stat6", "signaling", "for", "survival", "and", "proliferation", ",", "but", "have", "constitutively", "activated", "Stat3", "signaling", "."], "sentence": "Lymphoma cells are independent of IL4 / Stat6 signaling for survival and proliferation , but have constitutively activated Stat3 signaling .", "event_mentions": [], "entity_mentions": [{"id": "T10", "text": "IL4", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T11", "text": "Stat6", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T12", "text": "Stat3", "entity_type": "Protein", "start": 18, "end": 18}]}
{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "", "tokens": ["These", "same", "targets", "are", "also", "deregulated", "in", "wild-type", "B-1a", "lymphomas", "that", "arise", "spontaneously", "through", "age", "predisposition", "."], "sentence": "These same targets are also deregulated in wild-type B-1a lymphomas that arise spontaneously through age predisposition .", "event_mentions": [], "entity_mentions": [{"id": "T25", "text": "deregulated", "entity_type": "Regulation", "start": 5, "end": 5}]}
{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "S8", "tokens": ["These", "results", "suggest", "that", "Akt", ",", "NFkappaB", ",", "and", "Stat3", "pathways", "may", "serve", "as", "effective", "targets", "in", "the", "treatment", "of", "EBV", "-", "associated", "B", "cell", "lymphomas", "."], "sentence": "These results suggest that Akt , NFkappaB , and Stat3 pathways may serve as effective targets in the treatment of EBV - associated B cell lymphomas .", "event_mentions": [], "entity_mentions": [{"id": "T13", "text": "Akt", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T14", "text": "Stat3", "entity_type": "Protein", "start": 9, "end": 9}]}
{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "", "tokens": ["Author", "Summary"], "sentence": "Author Summary", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "", "tokens": ["Epstein-Barr", "virus", "(", "EBV", ")", "is", "linked", "to", "the", "development", "of", "multiple", "cancers", ",", "including", "post-transplant", "lymphoma", ",", "Hodgkin", "disease", ",", "and", "nasopharyngeal", "carcinoma", "."], "sentence": "Epstein-Barr virus ( EBV ) is linked to the development of multiple cancers , including post-transplant lymphoma , Hodgkin disease , and nasopharyngeal carcinoma .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "S11", "tokens": ["Latent", "membrane", "protein", "1", "(", "LMP1", ")", "is", "expressed", "in", "many", "EBV", "-", "associated", "cancers", "and", "is", "responsible", "for", "most", "of", "the", "altered", "cellular", "growth", "properties", "that", "are", "induced", "by", "EBV", "infection", "."], "sentence": "Latent membrane protein 1 ( LMP1 ) is expressed in many EBV - associated cancers and is responsible for most of the altered cellular growth properties that are induced by EBV infection .", "event_mentions": [{"id": "E8", "event_type": "Gene_expression", "trigger": {"text": "expressed", "start": 8, "end": 8}, "arguments": [{"entity_id": "T15", "text": "Latent membrane protein 1", "role": "Theme"}]}], "entity_mentions": [{"id": "T15", "text": "Latent membrane protein 1", "entity_type": "Protein", "start": 0, "end": 3}, {"id": "T16", "text": "LMP1", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T26", "text": "expressed", "entity_type": "Gene_expression", "start": 8, "end": 8}]}
{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "S12", "tokens": ["This", "study", "reveals", "that", "LMP1", "induces", "lymphomas", "in", "B-1a", "lymphocytes", ",", "a", "cell", "type", "that", "is", "susceptible", "to", "transformation", "in", "aged", "mice", "."], "sentence": "This study reveals that LMP1 induces lymphomas in B-1a lymphocytes , a cell type that is susceptible to transformation in aged mice .", "event_mentions": [], "entity_mentions": [{"id": "T17", "text": "LMP1", "entity_type": "Protein", "start": 4, "end": 4}]}
{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "S13", "tokens": ["The", "lymphomas", "require", "Akt", ",", "NFkappaB", ",", "and", "Stat3", "signaling", "for", "enhanced", "growth", "and", "survival", "."], "sentence": "The lymphomas require Akt , NFkappaB , and Stat3 signaling for enhanced growth and survival .", "event_mentions": [], "entity_mentions": [{"id": "T18", "text": "Akt", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T19", "text": "Stat3", "entity_type": "Protein", "start": 8, "end": 8}]}
{"doc_id": "PMC-2065877-00-TIAB.txt", "sent_id": "S14", "tokens": ["The", "activation", "of", "the", "Stat3", ",", "Akt", ",", "and", "NFkappaB", "signaling", "pathways", "likely", "underlies", "the", "ability", "of", "LMP1", "to", "promote", "malignant", "transformation", "."], "sentence": "The activation of the Stat3 , Akt , and NFkappaB signaling pathways likely underlies the ability of LMP1 to promote malignant transformation .", "event_mentions": [], "entity_mentions": [{"id": "T20", "text": "Stat3", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T21", "text": "Akt", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T22", "text": "LMP1", "entity_type": "Protein", "start": 17, "end": 17}]}
